ArticleAnnals of medicine2022

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.

Xi Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.